Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus FOLFOX in metastatic pancreatic cancer
NCT01666730Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Feb 2013
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in pancreatic adenocarcinoma (PDAC), sponsored by Case Comprehensive Cancer Center. Started Feb 2013; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01666730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666730.